RUCDRi002-A-72

General

Cell Line

hPSCreg name RUCDRi002-A-72
Cite as:
RUCDRi002-A-72
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
RUCDRi002-A
(TC-113, 50-001-21, 50-001-21.P20_10, ND50038, LiPSC-GR1.1, TC-1133)
RUCDRi002-A-63
(LVIP05-RB1-CS1)
RUCDRi002-A-64
(LVIP05-RB1-CS2)
RUCDRi002-A-65
(LVIP05-RB1-CS3)
Last update 26th February 2024
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Angios GmbH (ANGIOS)

External Databases

BioSamples SAMEA115345971

General Information

Projects
* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA4938814

Ethics

Also have a look at the ethics information for the parental line RUCDRi002-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line RUCDRi002-A.

Reprogramming method

Vector type Integrating
Vector Virus ()
Is the used vector excisable?
Unknown
Absence of reprogramming vector(s)?
Unknown
Reprogramming vectors silenced?

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium mTeSR™ Plus

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line RUCDRi002-A .

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
Gene knock-in
C13
GFP